Sit Investment Associates Inc Catalent, Inc. Transaction History

Sit Investment Associates Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	BUY	$72.74 - $92.5 $396,433 - $504,125	5,450 New	5,450 $260,000
Q4 2019 Feb 13, 2020	SELL	$47.06 - $56.64 $256,477 - $308,688	-5,450 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$47.45 - $58.05 $416,373 - $509,388	-8,775 Reduced 61.69%	5,450 $260,000
Q3 2018 Nov 14, 2018	SELL	$40.12 - $45.55 $128,383 - $145,760	-3,200 Reduced 18.36%	14,225 $648,000
Q2 2018 Jul 19, 2018	BUY	$38.72 - $42.52 $674,696 - $740,911	17,425 New	17,425 $730,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Sit Investment Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Sit Investment Associates Inc with notifications on news.